相关实验视频

Updated: Jun 5, 2025

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

在检查点抑制剂免疫治疗中,吸烟状态,毒性和生存率之间的关联

Anna Rudzińska¹, Pola Juchaniuk¹, Jakub Oberda¹

¹Department of Clinical Oncology and Chemotherapy, Medical University of Lublin, Lublin, Poland.

Frontiers in oncology

|December 10, 2024

概括

免疫检查点抑制剂 (ICI) 可以引起与免疫相关的不良事件 (irAEs). 这项研究没有发现吸烟和irAEs之间的联系,但吸烟包年显著影响了整体生存率和无进展生存率.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
临床医学临床医学

背景情况:

免疫检查点抑制剂 (ICI) 在癌症治疗中至关重要,增强抗瘤T细胞反应.
与免疫相关的不良事件 (irAEs) 是ICI治疗的一个重大问题,影响患者的结果.

研究的目的:

研究ICI治疗患者的IRAE和生存结果之间的关系.
探索吸烟状态和包装年对irAEs和治疗疗效的影响.

主要方法:

这是一项针对151名接受ICI治疗的患者的观察性单中心研究.
统计分析包括日志等级测试和多变量Cox比例危险模型.
吸烟状态和包装年被评估,以确定它们与irAEs和生存率的相关性.

主要成果:

38%的患者经历了irrAEs,最常见的是甲状腺功能障碍和皮肤毒性.
没有发现吸烟包年对毒性严重程度或发生的直接影响.
吸烟包年对整体存活率 (OS) 和无进展存活率 (PFS) 有显著影响.

结论:

吸烟状态与irAEs或治疗疗效没有相关性.
虽然吸烟没有影响irAEs,但累积吸烟 (包装年) 却对患者的生存结果产生了负面影响.
需要进一步的研究来探索吸烟对癌症治疗影响的其他潜在机制.

关键词:

癌症免疫疗法免疫疗法免疫检查点抑制剂免疫检查点抑制剂免疫疗法不良影响免疫疗法不良影响免疫疗法毒性免疫疗法毒性吸烟是为了吸烟.

更多相关视频

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations

Published on: January 10, 2015

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...